A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model

MLA

Amlan Das, et al. “A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett’s Adenocarcinoma in a Mouse Xenograft Model.” Molecular Cancer Therapeutics, vol. 12, no. 3, Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20045fab55521728ab38caa34019b6e3&authtype=sso&custid=ns315887.

APA

Amlan Das, Sushanta K. Banerjee, Mehmet Tanol, Suman Kambhampati, Peter J. Van Veldhuizen, Snigdha Banerjee, Emma Borrego-Diaz, Roger A. Rajewski, Douglas M. Burns, Inamul Haque, & Saheli Jha. (2013). A second-generation 2-Methoxyestradiol prodrug is effective against Barrett’s adenocarcinoma in a mouse xenograft model. Molecular Cancer Therapeutics, 12(3).

Chicago

Amlan Das, Sushanta K. Banerjee, Mehmet Tanol, Suman Kambhampati, Peter J. Van Veldhuizen, Snigdha Banerjee, Emma Borrego-Diaz, et al. 2013. “A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett’s Adenocarcinoma in a Mouse Xenograft Model.” Molecular Cancer Therapeutics 12 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20045fab55521728ab38caa34019b6e3&authtype=sso&custid=ns315887.